Genoscience Pharma evaluated their most advanced compound, GNS561, with INOVOTION chick embryo model
Genoscience Pharma evaluated their most advanced compound, GNS561, with INOVOTION chick embryo model.
Read morePrecision for Medicine Acquires Industry-leading Artificial Intelligence Technology
Precision for Medicine Acquires Industry-leading Artificial Intelligence Technology, Significantly Expands Cloud-based Multiomic Data Integration and Informatics Platform QuartzBio™
Read moreOSE Immunotherapeutics Announces Clinical Trial Authorization for a Phase 1 to Evaluate Selective SIRPα antagonist BI 765063
OSE Immunotherapeutics Announces Clinical Trial Authorization for a Phase 1 by two Health Agencies (France and Belgium) to Evaluate the Selective SIRPα antagonist BI 765063* under Development in Collaboration with Boehringer Ingelheim in Patients with Advanced Solid Tumors
Read morePX’THERAPEUTICS DEVELOPS ITS SERVICES OFFER
PX’Therapeutics, a French pioneer in the production of customized recombinant proteins, offers custom-made protein production for academic laboratories, companies and start-up that require quality proteins to perform preliminary studies (in-vitro/in-vivo).
Read morePerkin Elmer – new member
Partner with PerkinElmer to enhance and streamline your biotherapeutics workflow from target discovery to manufacturing and quality control.
Read more